Avastin bevacizumab regulatory update

FDA's Oncologic Drugs Advisory Committee voted 10-0 that the response seen with Avastin bevacizumab from Roche's Genentech Inc. unit in patients with previously treated glioblastoma multiforme (GBM) ...